Teva, biotech company Amgen end dispute over generic HPT drug
Israel-based drugmaker agrees to stop selling its generic product until its license date expires in mid-2021.
Tag: Teva
Teva chief reports 'strong progress' in restructuring plan
The chief executive of Israel's Teva Pharmaceuticals said Thursday that he was making "strong progress" on the company's restructuring plan, even ...